Arya News - The upcoming FDA advisory meeting is set to assess whether to allow pharmacies to produce seven different peptides.
( NewsNation ) — The Food and Drug Administration will hold a meeting in July about whether to ease restrictions on access to peptides, the trending, underregulated injectable substances gripping the wellness community.
Peptides have surged in popularity, rapidly entering the commercial mainstream as claims circulate about anti-aging, muscle growth and enhanced cognitive function. A “gray market” has emerged online to meet demand, according to PBS , with companies creating compounded or unapproved formulations and adding “for research use only” disclaimers.
Inside the booming, gray-market world of injectable peptides
About Our Ads
Yahoo! US Politics 2024 Election World Health Science The 360 Contact Us Originals Help Share Your Feedback About Us About Our Ads Site Map Follow us on
Download our app
© 2026 Yahoo. All rights reserved.
View comments